M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Relative Value

The Relative Value of one Middle East Pharmaceutical Industries Company SJSC stock under the Base Case scenario is 118.27 SAR. Compared to the current market price of 121.2 SAR, Middle East Pharmaceutical Industries Company SJSC is Overvalued by 2%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
118.27 SAR
Overvaluation 2%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
54
vs Industry
26
Median 3Y
4.8
Median 5Y
4.8
Industry
2.5
Forward
6.2
vs History
54
vs Industry
17
Median 3Y
25.5
Median 5Y
25.5
Industry
21.9
Forward
27.6
vs History
36
vs Industry
21
Median 3Y
23.2
Median 5Y
23.2
Industry
16.5
vs History
27
vs Industry
10
Median 3Y
93.7
Median 5Y
93.7
Industry
23.6
vs History
54
vs Industry
8
Median 3Y
7.9
Median 5Y
7.9
Industry
2.1
vs History
54
vs Industry
24
Median 3Y
4.8
Median 5Y
4.8
Industry
2.6
Forward
6.2
vs History
54
vs Industry
24
Median 3Y
7.8
Median 5Y
7.8
Industry
5.2
vs History
54
vs Industry
18
Median 3Y
19.4
Median 5Y
19.4
Industry
13.3
Forward
22.1
vs History
54
vs Industry
19
Median 3Y
21.6
Median 5Y
21.6
Industry
16.6
Forward
24.6
vs History
36
vs Industry
22
Median 3Y
23.3
Median 5Y
23.3
Industry
15.6
vs History
45
vs Industry
15
Median 3Y
33.3
Median 5Y
33.3
Industry
19.1
vs History
54
vs Industry
14
Median 3Y
6.4
Median 5Y
6.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Middle East Pharmaceutical Industries Company SJSC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SA
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
2.4B SAR 4.7 25 19 21.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top